| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000021691 |
| Receipt No. | R000024996 |
| Official scientific title of the study | Evaluation the effect of group culture in WOW dishes of human embryos on embryo development |
| Date of disclosure of the study information | 2016/04/01 |
| Last modified on | 2017/02/13 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Evaluation the effect of group culture in WOW dishes of human embryos on embryo development | |
| Title of the study (Brief title) | Effect of group culture in WOW dishes of human embryos on embryo development | |
| Region |
|
|
| Condition | ||
| Condition | Obstetrics and gynecology | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | In bovine, less than 10% of the embryos developed to the blastocyst stage when embryos are cultured individually, however when the embryos are cultured in groups, 25-35% of the embryos developed to the blastocysts. This tendency, i.e. improved embryo development in group culture, has also been demonstrated in other mammalian species, such as mouse, cat and human. The main reason for this beneficial outcome of group culture has been ascribed to the presence of growth factors, which are secreted by preimplantation embryos that act upon the embryo itself or the neighboring embryos. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Using Veeck criteria for classification for cleaved embryos on day-3 and Gardner criteria for classification for blastocysts on day-5, 6 and 7, we compare the rates of the blastocyst development and good quality blastocyst development between WOW group and control group. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | WOW dish culture(group culture) | |
| Interventions/Control_2 | Individual culture | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Patients whose embryos were fertilized by Conventional IVF/ICSI
Patients who had at least 3 fertilized oocytes (2PN) Patients whose whole 2PN embryos were cultured to the blastocyst stage |
|||
| Key exclusion criteria | Patients who were pointed out that there were an abnormality in the chromosome analysis.
Patients who had severely male factor and had to use testicular, epididymis and frozen sperm. Patients who had a severe disease of internal organ. Patients who were decided to be unsuitable for this study by doctors and researchers. |
|||
| Target sample size | 300 | |||
| Research contact person | |
| Name of lead principal investigator | Tomonori Ishikawa |
| Organization | Tokyo Medical and Dental University |
| Division name | Comprehensive Reproductive Medicine |
| Address | 1-5-45 Yushima, Bunkyo-Ku, Tokyo |
| TEL | 03-5803-5322 |
| t.ishikawa.crm@tmd.ac.jp | |
| Public contact | |
| Name of contact person | Tomonori Ishikawa |
| Organization | Tokyo Medical and Dental University |
| Division name | Comprehensive Reproductive Medicine |
| Address | 1-5-45 Yushima, Bunkyo-Ku, Tokyo |
| TEL | 03-5803-5322 |
| Homepage URL | |
| t.ishikawa.crm@tmd.ac.jp | |
| Sponsor | |
| Institute | Tokyo Medical and Dental University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Dai Nipponn Printing Co., Ltd |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024996 |